CompoAtlas

VISION

Food supplement declared in France, declaration No 2022-12-1154

VISION (BIOSENS) is a food supplement declared in France. Status: retrait du marché annoncé pour le 17 June 2028. 2 rules of use apply to its ingredients (limits and warnings).

Brand
BIOSENS
Food business operator placing the product on the market
NATURENVIE
Status
Retrait du marché annoncé pour le 17 June 2028
Form
Gélule
Daily dose
2 gélules
Directions for use
Prendre 2 gélules le matin
Intended populations
Personnes de plus de 60 ans, Homme, Femme
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, À prendre en dehors des repas, Enfants (moins de 12 ans), Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Œil / Vision

Declaration 190575, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Camellia sinensis (L.) KuntzeFeuilleExtrait sec aqueux300 mg
Ribes nigrum L.FruitPoudre (de plantes séchées ou broyées)300 mg
Vaccinium myrtillus L.BaieExtrait sec hydroalcoolique30 mg

Additives

E412

Other ingredients

Fécule de manioc, Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas prendre : à jeun, avec d’autres produits contenant du thé vert, en dehors des repas. Contient de la caféine (7.5mg/jour), de l’épigallocatéchine gallate (15mg/j). Ne pas dépasser 800mg d'épigallocatéchine gallate/jour.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : BIOSENS

Enter to analyse, Shift+Enter for a new line